Qube Research & Technologies LTD T2 Biosystems, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$0.46 - $0.94 $13,253 - $27,082	-28,811 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$0.86 - $1.21 $24,777 - $34,861	28,811 New	28,811 $26,000
Q2 2021 Aug 13, 2021	SELL	$1.04 - $1.69 $54,996 - $89,368	-52,881 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.32 - $3.79 $380,590 - $1.09 Million	-288,326 Reduced 84.5%	52,881 $86,000
Q4 2020 Feb 16, 2021	SELL	$1.06 - $1.51 $69,067 - $98,388	-65,158 Reduced 16.03%	341,207 $423,000
Q3 2020 Nov 12, 2020	BUY	$1.15 - $2.1 $318,359 - $581,351	276,834 Added 213.72%	406,365 $553,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.67 $62,174 - $216,316	129,531 New	129,531 $165,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $14.1M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.